title: Hesperidin, a flavonoid glycoside with sedative effect, decreases brain pERK1/2 levels in mice.
abstract: The aim of this work was to evaluate if the intraperitoneal administration of the natural compound hesperidin, in a sedative dose, and neo-hesperidin, a hesperidin structural analog that exerts minor sedative effect, were able to induce changes in intracellular signaling cascades in different areas of the brain. The systemic administration of hesperidin produced a marked reduction in the phosphorylation state of extracellular signal-regulated kinases 1/2 (ERK 1/2), but not of Ca(+2)/calmodulin-dependent protein kinase II alpha subunit (alphaCaMKII), in the cerebral cortex, cerebellum and hippocampus. In contrast, neo-hesperidin did not markedly affect the activity of ERK 1/2 in both the cortex and the cerebellum. Taken together, these results demonstrated that intracellular signalling involving a selective decrease in ERK1/2 activation accompanied the depressant action of hesperidin. Even more, the low sedative action of neo-hesperidin correlates with a negligible decrease in phosphorylation state of ERK 1/2 (pERK 1/2), suggesting that low levels of pERK 1/2 in CNS could be a marker of sedative efficacy of flavonoids.
authors.affiliation: Instituto de Biología Celular y Neurociencias, Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155, 3 degrees Piso, C1121ABG, Argentina.
authors.forename: M Cecilia
authors.initials: MC
authors.lastname: Martínez
authors.forename: Sebastian P
authors.initials: SP
authors.lastname: Fernandez
authors.forename: Leonardo M
authors.initials: LM
authors.lastname: Loscalzo
authors.forename: Cristina
authors.initials: C
authors.lastname: Wasowski
authors.forename: Alejandro C
authors.initials: AC
authors.lastname: Paladini
authors.forename: Mariel
authors.initials: M
authors.lastname: Marder
authors.forename: Jorge H
authors.initials: JH
authors.lastname: Medina
authors.forename: Haydée
authors.initials: H
authors.lastname: Viola
mesh_terms: D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001921:Brain / Q000187:drug effects* / Q000201:enzymology; D006569:Hesperidin / Q000494:pharmacology*; D006993:Hypnotics and Sedatives / Q000494:pharmacology*; D008297:Male; D051379:Mice; D019950:Mitogen-Activated Protein Kinase 1 / Q000378:metabolism*; D048052:Mitogen-Activated Protein Kinase 3 / Q000378:metabolism*; D010766:Phosphorylation; D015398:Signal Transduction
chemical_list: D006993:Hypnotics and Sedatives; D006569:Hesperidin; D019950:Mitogen-Activated Protein Kinase 1; D048052:Mitogen-Activated Protein Kinase 3